CAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research Collaboration

Shinshu University Hospital will contribute its expertise in CAR T-cell therapy research and development and clinical application. Teijin Regenet will bring manufacturing and quality-management expertise cultivated through its CDMO business for regenerative medicine products.

The collaboration is intended to give CAR T manufacturing in Japan a boost by combining clinical and R&D know-how with industrial production experience.